HUMAN PRESCRIPTION DRUG: 61314-625

Brand Name: CIMERLI

Generic Name: ranibizumab-eqrn

Primary Class: Vascular Endothelial Growth Factor Inhibitor [EPC]

SPL Set ID: 4b383d74-4830-4587-95f7-c32a39268df7 view on Dailymed | RXCUI: 2612675

Manufacturer Name: Sandoz Inc

Associated Package NDCs
Package NDC Description
61314-625-94 1 VIAL, SINGLE-DOSE in 1 CARTON (61314-625-94) / .05 mL in 1 VIAL, SINGLE-DOSE